Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Isodiol International Inc ISOLF

Healthcare Drug Manufacturers - Specialty & Generic Cannabis
Isodiol International Inc is a manufacturer and developer of phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. It generates revenue from the sale of nutritional health products derived from hemp. Geographically, it derives a majority of revenue from the United States and also has a presence in Canada. Its product categories include Tinctures... see more

Recent & Breaking News (GREY:ISOLF)

CSE Bulletin: Delist - Isodiol International Inc. (ISOL)

Newsfile December 6, 2021

Isodiol International Inc. Files Notice of Civil Claim Against Brain Bioceutical Corp for Breach of Contract & Update on Stock Trading Halt

TheNewsWire January 27, 2021

IIROC Trading Halt - ISOL

Canada NewsWire December 10, 2020

Isodiol Announces Conversion of Debentures

TheNewsWire November 5, 2020

Isodiol International Inc. Corporate Update Announces Final Restructuring Actions Including Trade Halt and Strategic International Growth Plans

TheNewsWire October 30, 2020

Isodiol Announces Conversion of Debentures

TheNewsWire October 28, 2020

Isodiol International Inc. Provides Bi-Weekly Status Report

TheNewsWire October 15, 2020

Isodiol International Inc. Provides Bi-Weekly Status Report

TheNewsWire September 29, 2020

Isodiol International Inc. Aligns with SalesBird for U.S. and Global Hemp CBD Product Distribution

TheNewsWire September 17, 2020

Isodiol International Inc. Default Announcement Pursuant to National Policy 12-203 Management Cease Trade Order Issued

TheNewsWire September 15, 2020

Isodiol International Inc. Corporate Update

TheNewsWire September 9, 2020

Isodiol International Inc. Provides Update to Delay in Filing Annual and Interim Financials

TheNewsWire August 31, 2020

Isodiol Announces Conversion of Debentures

TheNewsWire August 4, 2020

Isodiol International Inc. Announces Delay in Filing Annual Financial Statements

TheNewsWire July 30, 2020

Isodiol International Inc. Announces Sweeping Executive Management Changes

TheNewsWire July 27, 2020

Isodiol International Inc. Reports Third Quarter 2020 Financial Results

TheNewsWire July 17, 2020

Isodiol International, Inc Stock Price Increase

TheNewsWire June 9, 2020

Isodiol International Inc. Adds Andrew S. Alvis to its Board of Directors and Appointed Chairman of Audit Committee

TheNewsWire May 15, 2020

Isodiol International Inc. Provides Shareholder Update

Accesswire January 24, 2020

Isodiol International Inc. Reports Second Quarter 2020 Financial Results

Accesswire December 3, 2019